InvestorsHub Logo
Followers 88
Posts 8196
Boards Moderated 0
Alias Born 06/17/2013

Re: Yooperman post# 58043

Friday, 04/28/2023 11:23:20 AM

Friday, April 28, 2023 11:23:20 AM

Post# of 64653
and the odds go in favor of longs that hold startup positions,
when the IP level matches, or exceeds any other pharma related Bio.
What's the accumulated patented TSOI IPs ?, and then measure those IPs to other related IPS that are PRed from a Big Pharma subsidiary in the industry.

the potential levels in Bios are harder to evaluate, because most peeps cannot accept the debt level incurred in a longer time frame of product tarket completion.

each level takes a lot of time to absorb the info , and come up w/ a price

most day traders don't like the debt levels of bio tech startups.

it's the reverse splitting ones, that have their own pathway toward resolution.

But i'm in this one that hasn't done a Reverse Split. , and believe in the CEO Tim Dixon
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News